These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 38861856

  • 1. Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids.
    Lin X, Lin T, Liu M, Chen D, Chen J.
    Biomed Pharmacother; 2024 Jul; 176():116871. PubMed ID: 38861856
    [Abstract] [Full Text] [Related]

  • 2. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y, Bian R, Li Y, Gao Y, Liu Y, Xu Y, Song X, Zhang Y.
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun 20; 51(6):607-614. PubMed ID: 31074773
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
    Mei Y, Liao X, Zhu L, Yang H.
    J Biochem; 2020 Jun 01; 167(6):603-611. PubMed ID: 31960922
    [Abstract] [Full Text] [Related]

  • 4. Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids.
    Lin X, Chen D, Chu X, Luo L, Liu Z, Chen J.
    Phytomedicine; 2023 Jun 01; 114():154752. PubMed ID: 36948141
    [Abstract] [Full Text] [Related]

  • 5. Polyphyllin II inhibits breast cancer cell proliferation via the PI3K/Akt signaling pathway.
    Miao W, Wang Z, Gao J, Ohno Y.
    Mol Med Rep; 2024 Dec 01; 30(6):. PubMed ID: 39364737
    [Abstract] [Full Text] [Related]

  • 6. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S, Wang D, Zhang S, Huang X, Wang D, Ijaz M, Shi Y.
    Cancer Chemother Pharmacol; 2017 Oct 01; 80(4):685-696. PubMed ID: 28779263
    [Abstract] [Full Text] [Related]

  • 7. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
    Zhang T, Zhu X, Wu H, Jiang K, Zhao G, Shaukat A, Deng G, Qiu C.
    J Cell Mol Med; 2019 May 01; 23(5):3711-3723. PubMed ID: 30920152
    [Abstract] [Full Text] [Related]

  • 8. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS.
    Huang L, Lin H, Chen Q, Yu L, Bai D.
    BMC Cancer; 2019 Nov 29; 19(1):1159. PubMed ID: 31783821
    [Abstract] [Full Text] [Related]

  • 9. The antiandrogenic effect of neferine, liensinine, and isoliensinine by inhibiting 5-α-reductase and androgen receptor expression via PI3K/AKT signaling pathway in prostate cancer.
    Liu CM, Wu Z, Pan B, An L, Zhu C, Zhou J, Jiang Y.
    Pharmazie; 2021 May 01; 76(5):225-231. PubMed ID: 33964997
    [Abstract] [Full Text] [Related]

  • 10. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL, Guo L, Wang GH.
    Biomed Pharmacother; 2016 Oct 01; 83():526-535. PubMed ID: 27447121
    [Abstract] [Full Text] [Related]

  • 11. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation.
    Zhang D, Zhang Q, Zheng Y, Lu J.
    J Ethnopharmacol; 2020 Sep 15; 259():112984. PubMed ID: 32446927
    [Abstract] [Full Text] [Related]

  • 12. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
    Chang CH, Ou TT, Yang MY, Huang CC, Wang CJ.
    J Ethnopharmacol; 2016 Jul 21; 188():111-22. PubMed ID: 27178635
    [Abstract] [Full Text] [Related]

  • 13. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway.
    Yan H, Jung KH, Kim J, Rumman M, Oh MS, Hong SS.
    Biomed Pharmacother; 2018 Feb 21; 98():134-141. PubMed ID: 29253760
    [Abstract] [Full Text] [Related]

  • 14. A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
    Wang S, Zhang Y, Ren T, Wu Q, Lu H, Qin X, Liu Y, Ding H, Zhao Q.
    Cell Death Dis; 2020 Jun 30; 11(6):491. PubMed ID: 32606352
    [Abstract] [Full Text] [Related]

  • 15. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X, Qin T, Mao J, Zhang J, Fan S, Lu Y, Sun Z, Zhang Q, Song B, Li L.
    J Exp Clin Cancer Res; 2019 Jun 13; 38(1):256. PubMed ID: 31196157
    [Abstract] [Full Text] [Related]

  • 16. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM, Bai JY, Yang KX.
    IUBMB Life; 2018 Jun 13; 70(6):491-500. PubMed ID: 29637742
    [Abstract] [Full Text] [Related]

  • 17. Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes.
    Chen J, Lin X, He J, Liu D, He L, Zhang M, Luan H, Hu Y, Tao C, Wang Q.
    Clin Transl Med; 2022 Dec 13; 12(12):e1148. PubMed ID: 36536495
    [Abstract] [Full Text] [Related]

  • 18. Anti-breast-Cancer Activity Exerted by β-Sitosterol-d-glucoside from Sweet Potato via Upregulation of MicroRNA-10a and via the PI3K-Akt Signaling Pathway.
    Xu H, Li Y, Han B, Li Z, Wang B, Jiang P, Zhang J, Ma W, Zhou D, Li X, Ye X.
    J Agric Food Chem; 2018 Sep 19; 66(37):9704-9718. PubMed ID: 30160115
    [Abstract] [Full Text] [Related]

  • 19. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
    Gao X, Liu J, Fan D, Li X, Fang Z, Yan K, Fan Y.
    Oncol Rep; 2022 Feb 19; 47(2):. PubMed ID: 34935059
    [Abstract] [Full Text] [Related]

  • 20. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F, Liu Y, Dou X, Du C, Mao T, Liu X.
    Oxid Med Cell Longev; 2022 Feb 19; 2022():8245614. PubMed ID: 35116094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.